Standigm

Standigm is a biopharmaceutical company that uses artificial intelligence (AI) to streamline and accelerate the process of developing new medications. The company employs advanced AI platforms to identify novel drug targets, design compounds, and optimize lead molecules. Standigm’s technology covers various stages of drug discovery, from target identification to lead generation, with a focus on reducing costs and time compared to traditional methods.